Non-obstructive Urinary Retention, Overactive Bladder
Conditions
Brief summary
In the field of urology, sacral neuromodulation (SNM) is a well-accepted, second-line, minimally invasive treatment for patients with overactive bladder dry (OABD) or wet (OABW), and for patients with non-obstructive urinary retention (NOUR). Long-term vary between 50-60%. This study examines whether urodynamics can be used as a predictor for successful SNM therapy
Interventions
DIAGNOSTIC_TESTurodynamics
Bladder filling and pressure is measured by the insertion of probes within the bladder, urethra and anorectum.
Sponsors
Universiteit Antwerpen
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
* Overactive bladder * Non-obstructive urinary retention
Exclusion criteria
* Neurogenica disorder (e.g. cerebrovascular accident, spinal cord injury)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in bladder volume | 3 weeks | Change in bladder volume is measured before and after test procedure for sacral neuromodulation |
| Change in bladder sensation | 3 weeks | Bladder sensation is measured by a slider (indicating bladder fullness scaled from 0 to 100) before and after test procedure for sacral neuromodulation |
| Change in ice water test | 3 weeks | Ice water is infused in the bladder and incontinence upon insertion of the ice water is assessed before and after sacral neuromodulation |
Countries
Belgium
Contacts
Primary ContactStefan De Wachter, MD PhD FEBU
Outcome results
None listed